Cite

HARVARD Citation

    Wallace, K. et al. (n.d.). Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients With Crohn's Disease. American journal of gastroenterology. p. . [Online]. 
  
Back to record